Short-term role of the dietary total antioxidant capacity in two hypocaloric regimes on obese with metabolic syndrome symptoms: the RESMENA randomized controlled trial

  • Patricia Lopez-Legarrea1,

    Affiliated with

    • Rocio de la Iglesia1,

      Affiliated with

      • Itziar Abete2, 4,

        Affiliated with

        • Isabel Bondia-Pons1,

          Affiliated with

          • Santiago Navas-Carretero1, 4,

            Affiliated with

            • Lluis Forga3,

              Affiliated with

              • J Alfredo Martinez1, 4Email author and

                Affiliated with

                • M Angeles Zulet1, 4

                  Affiliated with

                  Nutrition & Metabolism201310:22

                  DOI: 10.1186/1743-7075-10-22

                  Received: 20 November 2012

                  Accepted: 22 January 2013

                  Published: 13 February 2013

                  Abstract

                  Background

                  Dietary strategies seem to be the most prescribed therapy in order to counteract obesity regarding not only calorie restriction, but also bioactive ingredients and the composition of the consumed foods. Dietary total antioxidant capacity (TAC) is gaining importance in order to assess the quality of the diet.

                  Methods

                  Ninety-six obese adults presenting metabolic syndrome (MetS) symptoms completed an 8-week intervention trial to evaluate the effects of a novel dietary program with changes in the nutrient distribution and meal frequency and to compare it with a dietary pattern based on the American Heart Association (AHA) guidelines.

                  Anthropometric and biochemical parameters were assessed at baseline and at the endpoint of the study, in addition to 48-hours food dietary records.

                  Results

                  Both diets equally (p > 0.05) improved MetS manifestations. Dietary TAC was the component which showed the major influence on body weight (p = 0.034), body mass index (p = 0.026), waist circumference (p = 0.083) and fat mass (p = 0.015) reductions. Transaminases (ALT and AST) levels (p = 0.062 and p = 0.004, respectively) were associated with lower TAC values.

                  Conclusion

                  RESMENA diet was as effective as AHA pattern for reducing MetS features. Dietary TAC was the most contributing factor involved in body weight and obesity related markers reduction.

                  Trial registration

                  http://​www.​clinicaltrials.​gov; NCT01087086

                  Keywords

                  Antioxidant Weight loss Energy restriction Macronutrient distribution Dietary components Nutritional profile

                  Background

                  The World Health Organization (WHO) estimates that at least 300 million people are obese nowadays [1]. Obesity, is strongly associated with comorbidities such as impaired glucose tolerance or diabetes, insulin resistance, dyslipidemia, hypertension, nonalcoholic fatty liver disease, hyperuricemia, and prothrombotic and proinflammatory states, which are related to the onset of metabolic syndrome (MetS) [24]. Also according to the WHO estimations, obesity prevalence rates will tend to increase in the next years. So that new effective proposals are needed in order to prevent/counteract the obesity onset and spread.

                  Dietary strategies are one of the most prescribed therapies to prevent/counteract overweight and obesity [5]. While dietetic programs have traditionally focused on calorie restriction, new nutritional alternatives are nowadays being investigated. They entail macronutrient distribution [6], meal frequency [7], consumption of bioactive ingredients, such as fiber [8] and n-3 fatty acids [9], glycemic index (GI)/glycemic load (GL) [10] or the dietary total antioxidant capacity (TAC) [11]. Dietary TAC is considered an appropriate approach to measure the cumulative antioxidant properties of food [12], despite its controversial use at evaluating the role of antioxidants in vivo[13]. Oxidative stress is suggested to be involved in the onset of several obesity-related disorders such as hypertension, dyslipidemia, type-2 Diabetes Mellitus and MetS [11]. In this context, dietary TAC is gaining importance as a valuable tool to investigate the relationship between diet and oxidative stress-related diseases [14]. Furthermore, the influence of the dietary TAC has been poorly investigated in the context of MetS.

                  Many studies have separately examined the impact of different dietary components, such as macronutrient distribution [15], meal frequency [7], fiber [8], n-3 fatty acids [16], GI/GL [17] or dietary TAC [18]. However, to date, they have not been integrated together on a dietetic plan based on habitual foods intake to combat excessive fat deposition. In this context, the RESMENA-S (MEtabolic Syndrome REduction in NAvarra-Spain) study (http://​www.​clinicaltrials.​gov; NCT01087086) [19] aimed at evaluating the effect of a novel dietary strategy involving a modified macronutrient distribution, higher meal frequency, increased fiber and n-3 fatty acids consumption, low GI/GL and high TAC food and at comparing it with the American Heart Association (AHA) guidelines, which is currently considered as a reference dietary pattern to reduce fat mass content and improve MetS markers [20].

                  Methods

                  Study population

                  One hundred and five (56 Male and 49 Female) caucasian adults (49 ± 10 years old) presenting obesity determined by a Body Mass Index (BMI) higher than 30 Kg/m2 (mean BMI = 35.85 ± 4.67 kg/m2) and at least two MetS signs according to the International Diabetes Federation criteria [21] were enrolled in the study and 96 of them completed the trial (Figure 1). The presence of psychiatric disturbances, eating disorders, chronic diseases related with the metabolism of nutrients, major body weight changes in the last three months and difficulties in changing food habits were considered as exclusion criteria. Subjects were recruited through local newspaper advertisements and the Department database. All subjects gave written informed consent (http://​www.​clinicaltrials.​gov; NCT01087086) as approved by the Ethics Committee of the University of Navarra (065/2009) and in accordance with the Declaration of Helsinki. There were 9 dropouts along the study period. Baseline characteristics are presented in Table 1.
                  http://static-content.springer.com/image/art%3A10.1186%2F1743-7075-10-22/MediaObjects/12986_2012_Article_523_Fig1_HTML.jpg
                  Figure 1

                  Flowchart of the study subjects from advertisement through to the end of the 8-week intervention.

                  Table 1

                  Selected anthropometric characteristics of the whole sample and categorized by gender at baseline

                  Variable

                  Total (n = 96)

                  Male

                  Female

                  p

                  Sex

                  -

                  51

                  45

                  -

                  Age (years)

                  49 ± 10

                  48 ± 9

                  50 ± 10

                  0.194

                  Weight (kg)

                  99.73 ± 17.85

                  108.28 ± 15.94

                  90.03 ± 14.76

                  <0.001

                  Height (m)

                  1.67 ± 0.11

                  1.74 ± 0.08

                  1.58 ± 0.07

                  <0.001

                  BMI (kg/m2)

                  35.84 ± 4.67

                  35.75 ± 4.38

                  35.96 ± 5.02

                  0.822

                  Waist circumference (cm)

                  111.10 ± 12.80

                  116.27 ± 10.04

                  105.24 ± 13.16

                  <0.001

                  Waist/Hip ratio

                  0.96 ± 0.10

                  1.03 ± 0.07

                  0.89 ± 0.08

                  <0.001

                  BMI, Body Mass Index.

                  For the sex variable it is reported the frequency of men and females. Mean and standard deviation data are shown concerning the remaining variables. p-value: Comparison between men and women baseline characteristics.

                  p < 0.05 was set-up as statistically significant.

                  Study protocol

                  A randomized, controlled trial was designed to compare the effect of two dietary strategies for weight loss with different macronutrient distribution on anthropometric measurements and biochemical markers in obese subjects with MetS manifestations. Participants were randomly assigned to the control or the experimental diet (Figure 1). The study was of six months duration in two sequential periods: one intervention period of 8 weeks in which subjects received nutritional assessment every 15 days followed by a self-control period of 4 months in which subjects followed the first period learned-habits. This work reports on the 8-weeks findings.

                  At each visit, anthropometric assessments and body composition by bioimpedance were measured. Fasting blood and 24-h urine samples were collected and body composition by Dual-energy X-ray Absorptiometry (DXA) was measured at baseline and at the endpoint of the intervention period.

                  Diets

                  Two energy-restricted diets were prescribed and compared. An energy restriction of 30% was applied to the total energy requirements of each patient. Resting metabolic rate was calculated using the Harris-Benedict equation where the Wilkens adjusted weight was applied. Then, physical activity factor was considered in order to calculate total energy requirements according to the “Food and Nutrition Board, National Research Council: Recommended Dietary Allowances: 10th ed.” [22]. The Control diet was based on the AHA guidelines [20], including 3–5 meals/day, a macronutrient distribution of 50–55% total caloric value from carbohydrates, 15% from proteins and 30% from lipids, a healthy fatty acids profile, an intake of fiber of 20–25 g/day and a cholesterol recommendation of < 300 mg/day (Table 2). The RESMENA diet was composed of 7 meals/day including breakfast, lunch, dinner, two snacks in the morning and other two in the afternoon. The macronutrient distribution was as following: 40% total caloric value from carbohydrates, 30% from proteins and 30% from lipids. This pattern also maintained a healthy fatty acids profile, an input of fiber of 20–25 g/day and a cholesterol content of < 300 mg/day. It included an increased input of n-3 fatty acids, an increased amount of natural antioxidants and focused on low GI/GL carbohydrates (Table 2).
                  Table 2

                  Comparisons of the habitual intake, the scheduled diets, the final intake and the adherence

                  Variable

                  Control group (n = 48)

                  RESMENA group (n = 48)

                  Habitual intake (day 0)

                  Scheduled diet

                  Final intake (day 60)

                  Habitual intake (day 0)

                  pa

                  Scheduled diet

                  pb

                  Final intake (day 60)

                  pc

                  Energy (kcal/day)

                  2103 ± 451

                  1412 ± 177

                  1352 ± 284

                  2277 ± 566

                  0.099

                  1395 ± 188

                  0.649

                  1337 ± 289

                  0.808

                  CHO (g/day)

                  186.74 ± 58.90 (35.52%)

                  178.58 ± 20.15 (50.59%)

                  132.37 ± 35.33 $$$ (39.16%)

                  201.66 ± 65.30 (35.43%)

                  0.243

                  128.65 ± 15.97 (36.89%)

                  <0.001

                  114.55 ± 31.10 $$ (34.26%)

                  0.013

                  Protein (g/day)

                  93.58 ± 21.63 (17.80%)

                  57.01 ± 5.78 (16.14%)

                  60.83 ± 17.16 (18.00%)

                  95.01 ± 20.06 (16.69%)

                  0.738

                  99.54 ± 13.43 (28.54%)

                  <0.001

                  78.20 ± 17.46 $$$ (23.39%)

                  <0.001

                  PQ

                  0.30 ± 0.05

                  0.31 ± 0.01

                  0.30 ± 0.05$

                  0.30 ± 0.05

                  0.594

                  0.34 ± 0.01

                  <0.001

                  0.28 ± 0.05$$$

                  0.070

                  Protein/CHO

                  0.54 ± 0.18

                  0.32 ± 0.01

                  0.48 ± 0.18$$$

                  0.50 ± 0.13

                  0.224

                  0.77 ± 0.01

                  <0.001

                  0.70 ± 0.15$$

                  <0.001

                  Total fats (g/day)

                  97.29 ± 27.00 (41.64%)

                  46.02 ± 8.69 (29.33%)

                  59.09 ± 15.51 $$$ (39.33%)

                  110.26 ± 31.84 (43.58%)

                  0.034

                  46.98 ± 7.07 (30.31%)

                  0.554

                  56.58 ± 17.28 $$$ (38.08%)

                  0.497

                  SFA (g/day)

                  28.89 ± 10.13 (12.36%)

                  14.02 ± 2.44 (8.94%)

                  14.48 ± 5.47 (9.64%)

                  34.85 ± 13.64 (13.76%)

                  0.017

                  12.70 ± 1.86 (8.19%)

                  0.004

                  16.08 ± 5.80 $$$ (10.82%)

                  0.181

                  MUFA (g/day)

                  47.35 ± 12.76 (20.26%)

                  20.59 ± 4.51 (13.12%)

                  32.25 ± 9.18 $$$ (21.47%)

                  51.90 ± 15.42 (20.52%)

                  0.118

                  18.96 ± 3.11 (12.23%)

                  0.042

                  24.65 ± 7.80 $$$ (16.59%)

                  <0.001

                  PUFA (g/day)

                  12.58 ± 3.80 (5.38%)

                  7.54 ± 1.20 (4.81%)

                  7.65 ± 2.87 (5.09%)

                  13.92 ± 3.79 (5.50%)

                  0.088

                  10.77 ± 1.31 (6.95%)

                  <0.001

                  10.91 ± 5.56 (7.34%)

                  0.001

                  n3-FA

                  0.46 ± 0.54

                  0.20 ± 0.05

                  0.20 ± 0.44

                  0.28 ± 0.43

                  0.079

                  0.83 ± 0.30

                  <0.001

                  0.37 ± 0.49$$$

                  0.096

                  Cholesterol (mg/day)

                  363.43 ± 142.46

                  157.94 ± 18.44

                  206.68 ± 140.82 $$$

                  424.43 ± 162.31

                  0.053

                  275.75 ± 46.51

                  <0.001

                  241.21 ± 105.00

                  0.196

                  Fiber (g/day)

                  20.07 ± 8.77

                  27.57 ± 1.33

                  18.75 ± 8.50 $$$

                  21.66 ± 9.69

                  0.400

                  22.84 ± 3.48

                  <0.001

                  20.61 ± 9.01

                  0.316

                  Glycemic Index (U)

                  579.55 ± 179.16

                  487.29 ± 12.21

                  367.48 ± 131.06$$$

                  685.13 ± 226.21

                  0.013

                  332.01 ± 38.04

                  <0.001

                  326.70 ± 121.11

                  0.131

                  Glycemic Load (U)

                  105.21 ± 43.52

                  63.77 ± 5.47

                  70.24 ± 35.70

                  117.32 ± 43.92

                  0.178

                  43.37 ± 5.04

                  <0.001

                  52.03 ± 26.40$

                  0.008

                  TAC (mmol/day)

                  7.36 ± 3.66

                  10.85 ± 0.36

                  8.88 ± 2.72$$$

                  8.22 ± 4.41

                  0.302

                  17.09 ± 0.62

                  <0.001

                  13.90 ± 5.05$$$

                  <0.001

                  HEI (points)

                  60.28 ± 11.92

                  86.21 ± 0.99

                  70.90 ± 12.75$$$

                  56.05 ± 11.11

                  0.075

                  91.39 ± 1.80

                  <0.001

                  74.41 ± 10.07$$$

                  0.836

                  Meal Frequency (meals/day)

                  4.65 ± 0.59

                  3-5

                  4.59 ± 0.67

                  5.30 ± 1.25

                  0.001

                  7

                  N.A

                  6.51 ± 1.06

                  <0.001

                  CHO, Carbohydrates; PQ, Protein Quality; SFA, Saturated Fatty Acids; MUFA, Mono Unsaturated Fatty Acids; PUFA, Poly Unsaturated Fatty Acids; n-3 FA, n-3 Fatty Acids; TAC, Total Antioxidant Capacity; HEI, Healthy Eating Index; NA, Not Applicable.

                  p < 0.05 was set-up as statistically significant. pa Differences between Control and RESMENA groups intake before starting the intervention. pb Differences between Control and RESMENA scheduled diets. pc Differences between Control and RESMENA groups intake at the end of the intervention. $ Differences between the scheduled diets and the real intake at final day in both Control and Resmena groups. $p < 0.05; $$p < 0.01; $$$p < 0.001.

                  Participants were provided a 7-day menu plan in the RESMENA group and a food exchange system plan in the Control group, as previously described [2]. Usual diet was assessed with a semiquantitative 136-item food frequency questionnaire previously validated in Spain for energy and nutrient intake [14]. A 48-hour weighed food record was required at the beginning and at the end of the study. Diet composition was analyzed using the DIAL software (Alce Ingenieria, Madrid, Spain). The sum of eicosapentaenoic fatty acid and docosahexaenoic fatty acid (EPA + DHA) obtained by the DIAL program was used to estimate n-3 fatty acids consumption. The Healthy Eating Index (HEI) was calculated using also the DIAL software as described elsewhere [23]. The program gives different values between 0 and 100 considering the servings per day of cereals, vegetables, fruits, dairy products and meat. It also takes into account the percentage of energy provided by total and saturated fats, the amount of cholesterol and sodium per day and the variety of the diet. The final score was classified in five categories: > 80 points indicates “excellent diet”; 71–80 points = “very good diet”; 61–70 points = “good diet”; 51–60 = “acceptable diet” and 0–50 points = “inadequate diet”. Protein Quality (PQ) was defined as the ratio of essential amino acid to total dietary protein [24]. Dietary TAC was calculated using the list from Carlsen et al. 2010, which takes into consideration raw or cooked food preparations [25]. They provide a list of the total antioxidant content (mmol/100 g) of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. The TAC value corresponding to the different scheduled/ingested servings per day was calculated. GI and GL were obtained from Foster-Powell et al. [26] (University of Sydney updated website database 2012).

                  Participants were asked to maintain their normal physical activity during the study, estimated with a 24-h recall at the beginning and the end of the intervention.

                  Anthropometric and biochemical assessments

                  Anthropometric measurements (body weight, height, waist and hip circumferences) were carried out with the subjects in their underwear. Body weight was measured to the nearest 0.1 kg using a Tanita SC-330, (Tanita corp, Japan). Height was estimated with a stadiometer (Seca 713 model, Postfach, Germany) to the nearest 1 mm. BMI was calculated as the body weight divided by the squared height (kg/m2). Waist and hip circumferences were measured with a commercial measure tap following validated protocols [19]. Total body fat was measured by a bioelectric impedance Tanita SC-330 (Tanita corp, Japan) and by DXA (Lunar Prodigy, software version 6.0, Madison, WI) as described elsewhere [19].

                  Glucose, total cholesterol, high density lipoprotein-cholesterol (HDL-c), triglycerides, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) serum concentrations were measured in an autoanalyser Pentra C-200 (HORIBA ABX, Madrid, Spain) with specific kits. Insulin concentrations were determined by an enzyme-linked immunosorbent assay kit (Mercodia, Uppsala, Sweden) in a Triturus autoanalyzer (Grifols SA, Barcelona, Spain). Insulin resistance was estimated by the HOMA index {HOMA-IR = [glucose (mmol/L) × insulin (μU/ml)]/22,5} [5]. Low-density lipoprotein-cholesterol (LDL-c) levels were calculated following the Friedewald formula: LDL-c = TC-HDL-c - VLDL [10].

                  Statistical analyses

                  The results are expressed as mean ± SD. Normality distributions of the measured variables were determined according to the Shapiro–Wilk test. Differences between the beginning and the end of the period were analyzed by a paired t-test. Only those completely the study were analysed. The analysis between both diets (RESMENA vs. Control) was performed through an independent measures t-test. A linear regression analysis was applied to assess the potential relationships and associations among the different components of the diet and anthropometrical and biochemical parameters variation. Chi-square test was carried out to compare the percentage of participants from Control and RESMENA dietary groups included in the high-TAC group. A two-way ANOVA was performed in order to assess diet and sex interactions. Analyses were carried out using SPSS 15.1 software for Windows (SPSS Inc, Chicago, USA). Values of p < 0.05 were considered as statistically significant.

                  Results

                  Food intake assessment

                  There were available data about food intake of 90 participants (48 from Control group and 42 from RESMENA group). No differences were found in food energy intake between the experimental groups at the study baseline, except for total fat and saturated fat intake, GI and meal frequency (Table 2).

                  The RESMENA group reported a significantly higher protein and lower carbohydrate intake and the protein/carbohydrate ratio was also higher in this group at the end of the study (Table 2). There were no significant differences between groups either for PQ or total fat intake, but significant differences were found regarding fatty acids profile (Table 2). There were no significant differences in cholesterol intake after the intervention. Concurrently, no differences were found in fiber intake, neither in GI or HEI score. GL was significantly lower (p = 0.008) and TAC significantly higher (p < 0.001) in RESMENA group, with respect to the AHA group. As designed, consuming the RESMENA diet had an average intake (6.5 meals/day) significantly higher than the control one (4.5 meals/day).

                  The analysis of 48-h food records showed that in both groups the energy intake was in accordance with the prescribed patterns (Table 2). Protein, saturated fatty acid, polyunsaturated fatty acid (PUFA) and n-3 fatty acids intakes, as well as GL and meal frequency of the Control diet were in agreement with the scheduled pattern (Table 2). RESMENA group adjusted to PUFA, cholesterol and fiber intake and also the GI and meal frequency. RESMENA group did not reach completely the expected values of some components although it achieved an improvement comparing to baseline values.

                  Anthropometric and biochemical parameters

                  Energy restriction resulted in a mean body weight loss of 6.73 ± 0.71 kg in the Control diet and 7.09 ± 0.82 kg in the RESMENA diet, with no statistical differences between groups (Table 3). Consequently, BMI was significantly lowered in both groups. Every anthropometrical parameter was significantly reduced after the slimming treatments, with no differences between both dietary groups (Table 3). Control and RESMENA groups significantly reduced total cholesterol and triglycerides but there was no significant reduction in LDL-c. Only the AHA group had a significant decrease of the HDL-c values (p = 0.001). No changes were observed in the atherogenic ratios TC:HDL-c and LDL-c:HDL-c in none of the groups. Both groups significantly improved glucose metabolism (Table 3). The Control diet, but not the RESMENA one induced a significant reduction in ALT (p < 0.001 vs. p = 0.936) and AST (p = 0.001 vs. p = 0.740) transaminases levels, obtaining significant differences among groups (Table 3). No differences between groups were found in any of the other biochemical parameters (Table 3).
                  Table 3

                  Changes in selected parameters in Control and RESMENA groups after 8 weeks of nutritional intervention

                  Variable

                  Control group (n = 48)

                  Resmena group (n = 48)

                   

                  Visit 1 (day 0)

                  Visit 2 (day 60)

                  p a

                  Visit 1 (day 0)

                  Visit 2 (day 60)

                  p b

                  p c

                  Weight (kg)

                  99.45 ± 19.21

                  92.72 ± 18.50

                  <0.001

                  100.00 ± 16.58

                  92.91 ± 15.76

                  <0.001

                  0.555

                  BMI (kg/m2)

                  36.15 ± 4.95

                  33.70 ± 4.80

                  <0.001

                  35.55 ± 4.40

                  33.03 ± 4.24

                  <0.001

                  0.732

                  Waist circumference (cm)

                  110.94 ± 13.41

                  104.18 ± 12.29

                  <0.001

                  111.25 ± 12.30

                  103.78 ± 11.66

                  <0.001

                  0.432

                  Waist/hip ratio

                  0.96 ± 0.10

                  0.94 ± 0.09

                  <0.001

                  0.96 ± 0.10

                  0.93 ± 0.10

                  <0.001

                  0.355

                  Bioimpedance Fat mass (kg)

                  38.97 ± 10.87

                  33.68 ± 10.22

                  <0.001

                  39.23 ± 9.50

                  33.84 ± 9.09

                  <0.001

                  0.886

                  DXA Fat mass (kg)

                  42.13 ± 10.18

                  37.50 ± 10.39

                  <0.001

                  42.56 ± 9.18

                  37.30 ± 8.95

                  <0.001

                  0.208

                  TC (mg/dl)

                  221 ± 39

                  204 ± 39

                  0.001

                  219 ± 48

                  203 ± 46

                  0.020

                  0.943

                  HDL-c (mg/dl)

                  46 ± 10

                  42 ± 9

                  0.001

                  43 ± 10

                  41 ± 10

                  0.050

                  0.158

                  LDL-c (mg/dl)

                  140 ± 36

                  133 ± 35

                  0.085

                  137 ± 41

                  131 ± 40

                  0.374

                  0.888

                  TC/HDL-c ratio

                  4.94 ± 1.02

                  4.96 ± 0.94

                  0.856

                  5.18 ± 1.24

                  5.04 ± 1.24

                  0.398

                  0.419

                  LDL-c/HDL-c ratio

                  3.09 ± 0.77

                  3.22 ± 0.78

                  0.178

                  3.20 ± 0.83

                  3.23 ± 0.92

                  0.803

                  0.623

                  TG (mg/dl)

                  176 ± 10

                  145 ± 70

                  0.005

                  194 ± 123

                  151 ± 99

                  <0.001

                  0.421

                  Glucose (mg/dl)

                  121.02 ± 33.87

                  107.98 ± 13.71

                  0.006

                  123.81 ± 37.82

                  110.22 ± 26.18

                  0.016

                  0.939

                  Insulin (IU/mg)

                  15.30 ± 11.46

                  9.32 ± 7.18

                  <0.001

                  14.36 ± 8.30

                  9.14 ± 6.13

                  <0.001

                  0.557

                  HOMA index

                  4.69 ± 3.77

                  2.61 ± 2.31

                  <0.001

                  4.48 ± 3.01

                  2.60 ± 2.00

                  <0.001

                  0.686

                  ALT (U/L)

                  37.60 ± 21.04

                  27.03 ± 10.70

                  <0.001

                  29.13 ± 11.59

                  29.28 ± 14.20

                  0.936

                  0.001

                  AST (U/L)

                  25.81 ± 10.84

                  20.68 ± 6.18

                  0.001

                  21.90 ± 6.01

                  22.20 ± 6.14

                  0.740

                  0.002

                  BMI, Body Mass Index; DXA, Dual-energy X-ray Absorptiometry; HDL-c, High Density Lipoprotein-cholesterol; LDL-c, Low Density Lipoprotein-cholesterol; TG, Triglycerides; HOMA, Homeostasis Model Assessment; ALT, Alanine aminotransferase; AST, Aspartate aminotranferase. p < 0.05 was set-up as statistically significant.

                  p a differences between baseline and final values in Control group. p b differences between baseline and final values in RESMENA group. pc differences between changes in Control group as compared with RESMENA group at the end of the intervention.

                  Dietary TAC was the major influential factor, as body weight (p = 0.034), BMI (p = 0.026), fat mass (p = 0.015) and AST (p = 0.004) were significantly improved by this variable (Table 4). Dietary TAC also seemed to have a potential effect in ALT variations (p = 0.062). Concerning GI/GL, a trend towards an influence of insulin was found (Table 4). Since dietary TAC seemed to be the most influencing variable among the dietary analyzed elements, we categorized the sample considering the median value in: high- TAC (> 10.629 mmol day-1) or low- TAC (<10.629 mmol day-1) (Figure 2). As expected, the percentage of subjects from the RESMENA group (71%) included in the high-TAC group was significantly higher (p < 0.001) as compared with the Control group (29%). Body weight losses were marginally (p = 0.066) different when the subjects were categorized by the dietary TAC (Figure 2). Thus, the group with a higher dietary TAC showed a greater body weight reduction (−7.52 ± 0.64 kg) when compared with the low-TAC group (−6.35 ± 0.86 kg). Waist circumference decreased marginally towards significant differences between the two groups (p = 0.082) being greater in the high-TAC one (−7.77 ± 2.07 cm vs. -6.15 ± 0.31 cm). Fat mass was significantly reduced in both TAC groups and differences between them regarding densitometry fat mass kilograms (p = 0.026) were found. The low-TAC group significantly reduces ALT (p = 0.001) and AST (p = 0.002) transaminases levels, being statistically significant regarding the high-TAC group (p = 0.044 and p = 0.004, respectively) (Figure 2).
                  Table 4

                  Regression analysis, with change in phenotypical measurements as dependent variable and dietary components as the independent

                   

                  Meal Frequency

                  Protein Intake

                  n-3 FA intake

                  TAC

                  GI

                  GL

                  HEI

                  Model p

                  Corrected r2

                  Variable

                  B

                  p

                  B

                  p

                  B

                  p

                  B

                  p

                  B

                  p

                  B

                  p

                  B

                  p

                  Weight (Kg)

                  0.899

                  0.146

                  0.806

                  0.206

                  0.252

                  0.681

                  1.274

                  0.034

                  0.085

                  0.889

                  −0.519

                  0.399

                  1.140

                  0.059

                  0.024

                  0.122

                  BMI (kg/m2)

                  0.275

                  0.215

                  0.218

                  0.342

                  0.032

                  0.884

                  0.480

                  0.026

                  −0.025

                  0.910

                  −0.194

                  0.378

                  0.430

                  0.047

                  0.132

                  0.060

                  Waist circumference (cm)

                  0.731

                  0.446

                  1.392

                  0.157

                  −0.107

                  0.910

                  1.618

                  0.083

                  0.064

                  0.946

                  −0.722

                  0.447

                  0.624

                  0.508

                  0.559

                  −0.014

                  Bioimpedance

                  Fat mass (kg)

                  0.613

                  0.394

                  −0.036

                  0.962

                  1.358

                  0.053

                  1.185

                  0.091

                  −0.215

                  0.760

                  −0.424

                  0.552

                  0.639

                  0.365

                  0.128

                  0.061

                  DXA

                  Fat mass (kg)

                  0.949

                  0.063

                  0.819

                  0.120

                  0.434

                  0.392

                  1.211

                  0.015

                  0.050

                  0.921

                  0.154

                  0.763

                  0.806

                  0.109

                  0.133

                  0.059

                  Total Cholesterol (mg/dl)

                  3.886

                  0.670

                  0.444

                  0.962

                  −13.795

                  0.123

                  5.041

                  0.573

                  −2.462

                  0.783

                  −8.968

                  0.319

                  −16.091

                  0.071

                  0.381

                  0.010

                  HDL-c (mg/dl)

                  −0.786

                  0.612

                  −2.045

                  0.199

                  −2.055

                  0.178

                  0.558

                  0.714

                  −0.951

                  0.531

                  −1.558

                  0.308

                  −0.247

                  0.872

                  0.311

                  0.021

                  LDL-c (mg/dl)

                  5.174

                  0.522

                  1.930

                  0.817

                  −13.268

                  0.095

                  −0.164

                  0.984

                  −2.581

                  0.745

                  −4.266

                  0.594

                  −13.979

                  0.077

                  0.348

                  0.015

                  TG (mg/dl)

                  −2.511

                  0.865

                  2.792

                  0.855

                  7.639

                  0.601

                  23.238

                  0.107

                  5.349

                  0.712

                  −15.720

                  0.281

                  −9.324

                  0.522

                  0.471

                  −0.003

                  Glucose (mg/dl)

                  3.560

                  0.648

                  −8.493

                  0.290

                  6.908

                  0.370

                  −5.614

                  0.464

                  2.408

                  0.753

                  7.928

                  0.303

                  9.467

                  0217

                  0.781

                  −0.035

                  Insulin (IU/mg)

                  −1.662

                  0.233

                  −1.144

                  0.427

                  −1.814

                  0.188

                  −0.664

                  0.629

                  −2.546

                  0.061

                  −2.572

                  0.060

                  −1.597

                  0.246

                  0.198

                  −0.063

                  HOMA

                  −0.539

                  0.299

                  −0.487

                  0.364

                  −0.151

                  0.770

                  −0.371

                  0.468

                  −0.666

                  0.190

                  −0.465

                  0.365

                  −0.382

                  0.457

                  0.894

                  0.044

                  ALT (U/L)

                  −6.226

                  0.049

                  −6.852

                  0.035

                  −4.413

                  0.160

                  −5.795

                  0.062

                  3.721

                  0.232

                  3.708

                  0.238

                  5.855

                  0.060

                  0.066

                  0.089

                  AST (U/L)

                  −3.557

                  0.051

                  −4.539

                  0.015

                  0.084

                  0.963

                  −5.046

                  0.004

                  1.610

                  0.371

                  1.580

                  0.384

                  4.699

                  0.008

                  0.020

                  0.131

                  n-3 FA, n-3 Fatty Acids; TAC, Total Antioxidant Capacity; GI, Glycemic Index: GL, Glycemic Load; HEI, Healthy Eating Index; BMI, Body Mass Index; DXA, Dual-energy X-ray Absorptiometry; HDL-c, High Density Lipoprotein-cholesterol; LDL-c, Low Density Lipoprotein-cholesterol; TG, Triglycerides; HOMA, Homeostasis Model Assessment; ALT, Alanine minotransferase; AST, Aspartate aminotranferase. p < 0.05 was set-up as statistically significant.

                  http://static-content.springer.com/image/art%3A10.1186%2F1743-7075-10-22/MediaObjects/12986_2012_Article_523_Fig2_HTML.jpg
                  Figure 2

                  Changes on selected parameters categorized by low (<10.629 mmol day -1 , n = 45) or high (>10.629 mmol day -1 , n = 45) Total Antioxidant Capacity. BMI: Body Mass Index; ALT: Alanine aminotransferase; AST: Aspartate aminotranferase. p-values comparing the differences between low-TAC and high-TAC groups.

                  As expected, gender variation influenced anthropometrical and biochemical parameters changes (Table 5). Body weight loss was significantly higher in males than in females (p = 0.008), as well as fat mass reduction (p = 0.042) (Figure 3). Interestingly, men showed a statistically significant decrease of insulin blood levels (p = 0.020). Concurrently, ALT values were significantly reduced in men, while we did not found any changes in this marker in females group (Figure 3). Regarding dietary TAC influence, differences concerning gender were found. Women with higher TAC levels, showed a significantly greater reduction of body weight (p = 0.019), BMI (p = 0.028) and fat mass (p = 0.007), while there were not any variable differences between high or low TAC in the male group.
                  Table 5

                  Analysis assessing diet and sex interactions concerning anthropometric and biochemical markers

                  Variable

                  Groups

                  ANOVA 2×2

                   

                  Control-men (n = 27)

                  Control-women (n = 21)

                  RESMENA-men (n = 24)

                  RESMENA-women (n = 24)

                  DIET

                  SEX

                  Diet* sex

                  ΔWeight (Kg)

                  −7.60 ± 3.29

                  −5.61 ± 2.49

                  −7.73 ± 2.58

                  −6.45 ± 3.09

                  0.416

                  0.007

                  0.550

                  ΔBMI (kg/m2)

                  −2.56 ± 1.12

                  −2.29 ± 1.03

                  −2.55 ± 0.90

                  −2.49 ± 1.10

                  0.677

                  0.452

                  0.620

                  ΔWaist circumference (cm)

                  −6.57 ± 4.02

                  −7.01 ± 5.87

                  −8.15 ± 2.88

                  −6.80 ± 4.65

                  0.454

                  0.620

                  0.324

                  ΔBioimpedance Fat mass (kg)

                  −6.08 ± 4.92

                  −4.28 ± 1.84

                  −5.90 ± 2.64

                  −4.89 ± 3.50

                  0.764

                  0.054

                  0.582

                  ΔDXA Fat mass (kg)

                  −5.13 ± 2.80

                  −3.99 ± 1.49

                  −5.71 ± 1.95

                  −4.78 ± 2.75

                  0.156

                  0.034

                  0.835

                  ΔTotal Cholesterol (mg/dl)

                  −15.31 ± 35.58

                  −19.05 ± 30.86

                  −22.25 ± 44.19

                  −10.42 ± 49.55

                  0.921

                  0.635

                  0.362

                  ΔHDL-c (mg/dl)

                  −2.01 ± 7.10

                  −6.67 ± 6.98

                  −0.61 ± 7.29

                  −3.32 ± 6.03

                  0.098

                  0.011

                  0.495

                  ΔLDL-c (mg/dl)

                  −6.12 ± 25.04

                  −7.48 ± 27.41

                  −10.82 ± 40.17

                  −0.51 ± 47.30

                  0.880

                  0.553

                  0.440

                  ΔTG (mg/dl)

                  −35.88 ± 78.11

                  −24.50 ± 61.90

                  −54.08 ± 88.48

                  −32.96 ± 69.79

                  0.399

                  0.304

                  0.757

                  ΔGlucose (mg/dl)

                  −18.53 ± 36.01

                  −5.91 ± 19.86

                  −7.33 ± 26.55

                  −19.84 ± 46.17

                  0.847

                  0.994

                  0.079

                  ΔInsulin (IU/mg)

                  −7.68 ± 9.02

                  −3.37 ± 3.58

                  −6.26 ± 5.02

                  −4.16 ± 5.25

                  0.690

                  0.022

                  0.486

                  ΔHOMA

                  −2.64 ± 2.65

                  −1.35 ± 1.68

                  −1.74 ± 1.63

                  −2.02 ± 2.83

                  0.818

                  0.293

                  0.099

                  ΔALT (U/L)

                  −13.68 ± 19.36

                  −6.52 ± 12.77

                  −3.33 ± 10.70

                  3.64 ± 15.38

                  0.001

                  0.026

                  0.975

                  ΔAST (U/L)

                  −6.49 ± 11.74

                  −3.37 ± 6.16

                  −0.28 ± 6.13

                  0.88 ± 6.51

                  0.003

                  0.210

                  0.562

                  BMI, Body Mass Index; DXA, Dual-energy X-ray Absorptiometry; HDL-c, High Density Lipoprotein-cholesterol; LDL-c, Low Density Lipoprotein-cholesterol; TG, Triglycerides; HOMA, Homeostasis Model Assessment; ALT, Alanine aminotransferase; AST, Aspartate aminotranferase. p < 0.05 was set-up as statistically significant.

                  http://static-content.springer.com/image/art%3A10.1186%2F1743-7075-10-22/MediaObjects/12986_2012_Article_523_Fig3_HTML.jpg
                  Figure 3

                  Changes on anthropometric and biochemical selected parameters regarding gender, male (n = 51) or female (n = 45). HDL-c: High Density Lipoprotein-cholesterol; ALT: Alanine aminotransferase. p -values comparing the differences between male and female groups.

                  Discussion

                  This study compared the effects of a novel dietary strategy with the AHA pattern [20], considered to be effective to counteract obesity. To our knowledge, this is a pioneer intervention study in patients with MetS features evaluating the effects of an energy restricted diet based on food selection, including a modified macronutrient distribution, an increase in meal frequency, as well as the presence of bioactive ingredients, such as fiber and n-3 fatty acids, and controlling the GI/GL, dietary TAC and HEI score [19].

                  Evaluating the two prescribed dietary strategies as a whole, both were for weight loss and improved anthropometric and biochemical markers, with minor differences between them. Waist circumference was reduced in all the participants. However, when considering the IDF criteria for abdominal obesity (> 90 cm. in men and > 80 cm. in women) 4 people reached lower values after the dietary intervention (1 man and 1 woman from the Control group, 1 man and 1 woman from the RESMENA group).

                  Specifically, the individual role of each diet component was analyzed in order to assess the dietary components with major influence on these measurements in a MetS sample. In this sense, several works have studied dietary components effects separately in humans, but available results are controversial [5, 7, 13].

                  Recent investigations have focused on the role of the macronutrient distribution in weight reduction treatments instead of considering only calorie restriction [27]. In this context, increasing the dietary protein content has been a frequently-used strategy, due to the increased satiety with a reduction of energy intake in subsequent meals and the higher thermogenic effect attributed to them [6, 27]. Thus, in the current work it was prescribed a dietary pattern including the 30% of total caloric value as protein at the expense of carbohydrates (40% total caloric value). This profile did not apparently induce changes on any anthropometrical parameters between the experimental groups. Different studies have shown high-protein intake effects in relation with body weight changes, specifically on weight regain. However, those effects were found in the long-term [10] while the present work focused on the effects of an 8-week dietary treatment.

                  Interestingly, our study showed an inverse association between protein intake and both ALT and AST transaminases levels. These enzymes are unspecific markers of hepatic function [28]. Low-serum transaminases levels are found under normal conditions, indicating proper function of the liver, while increased serum values are related to hepatic dysfunction [28]. They have shown a correlation with insulin resistance and later development of diabetes, liver lipid content and features of non-alcoholic fatty liver disease. The experimental data are consistent with those other studies and suggest that moderately-high protein diets could influence negatively liver function. Concerning transaminases modification, it is important to notice that some differences were found before starting the intervention. For that reason we performed a percentage of change analyses in addition to the absolute values approach, in order to attenuate the possible bias. However, similar outcomes were obtained when applying this analysis, therefore, absolute values were maintained in Table 3.

                  Regarding the increased meal frequency, no differences in body weight loss in the context of iso-energetic energy-restricted diets were found, as also was reported by Cameron et al. 2009 [7]. Nevertheless, a direct relationship between increased meal frequency and the loss of fat mass was observed. With respect to biochemical parameters, no influences were found. However, Heden et al. 2012 observed that meal frequency differentially altered triglycerides and insulin postprandial concentrations [29].

                  The beneficial properties of n-3 fatty acids have been widely studied [9, 16]. In our study, a positive relationship between n-3 fatty acids intake and the reduction of fat mass was detected, being consistent with previous human studies [16].

                  GI and GL are two concepts that refer to the absorption rate of carbohydrates [26]. Increased values have been reported as potential type-2 Diabetes Mellitus risk factors [5]. In this sense, an encouraging result was obtained in our study, since we found a trend towards a reduction in insulin levels related to lower values of GI and GL in diet, in agreement with Bao et al. 2010 [30].

                  In order to assess the quality of the diet, numerous authors have designed and developed indexes or scores such as the Healthy Eating Index, the Alternate Healthy Eating Index or the Diet Quality Index and derivatives [14]. Most of them, take into consideration the Mediterranean Diet guidelines, widely recognized as a healthy pattern [30]. They consist on a single score that results from computing different component such as foods, food groups or a combination of foods and nutrients. In this context the HEI score was selected, obtained from the DIAL software. It takes into account macro and micronutrients intake, as well as food variety, to design the RESMENA diet. Considering the HEI score, a trend towards influencing weight loss and total cholesterol, LDL-c, ALT and AST levels was found. Other works evaluating Mediterranean-based patterns reported similar results regarding lipid metabolism and hepatic function markers [31, 32].

                  The most relevant finding of this study is in relation to dietary TAC. This parameter has been recently considered as a useful tool to assess the effects of dietary antioxidants, since it has been positively associated with plasma total antioxidant capacity [33]. After 8 weeks of intervention, we evidenced positive associations between the dietary TAC and the reduction of weight, BMI, waist circumference and fat mass. Regarding these anthropometric measurements, our findings are in accordance with previous studies that also reported benefits of dietary TAC and antioxidants compounds on adiposity and obesity indicators [31, 34]. This link may be associated with a reduction of cardiovascular risk, as previously described in other populations [35]. We also found an effect on ALT and AST transaminases suggesting an impact of the dietary TAC on hepatic metabolism. These data suggest that dietary TAC, as a measure of antioxidant intake, must be useful to assess the role of antioxidant intake as a single factor in the field of antioxidant consumption and disease prevention or therapy.

                  Contrary to most of the evaluated parameters, HDL-c values did not improve with none of the dietary treatments, which can be explained by the fact that the reduction on total cholesterol entails a reduction of this cholesterol fraction too, as previously reported by other researchers [36]. However, some other authors found higher HDL-c serum levels after similar dietary interventions [37] especially when containing fish or fish derived products [16, 38]. Despite our dietary strategy also focused on n-3 fatty acids intake, the participants did not reach a perfect adherence to this point, so that this can also contribute to the fact that HDL-c was found to decrease after the dietary intervention. Other important factor in relation to HDL-c is physical activity. In this sense, the participants were asked to maintain the normal activity and no exercise advice was given, which may allow discard differences due to physical activity changes.

                  Differences between males and females regarding anthropometric and biochemical parameters have been widely investigated [1, 7, 39]. In this sense, we analyzed gender influence on the studied variable changes. Body weight loss was higher in men than women, due to the also higher restriction regarding absolute amount of calories. This greater reduction of weight was accompanied by an also higher decrease of fat mass, as previously reported [7]. Regarding biochemical parameters, insulin as well as ALT blood levels were significantly decreased within this group in accordance with previous studies [1]. On the contrary, HDL-c reduction was greater among the women group, as other studies reported [40], which confirms the influence of sex on this cholesterol fraction. Taken together, these outcomes indicate that gender may be taken into account in order to design specific dietary plans for males and females.

                  This work could benefit of increasing sample size. Additionally, although the adherence to the diet was acceptable, this kind of treatments could show higher benefits when reaching a stricter follow-up of the dietary pattern. On the other hand, we have analyzed the effects of this treatment on obese adults with MetS features. The effectiveness of this pattern should be also evaluated in a younger population since obesity and MetS rates have increased alarmingly among childhood [41] and they represent a development problem [42] leading to an increased morbimortality at the adult age [43].

                  Conclusion

                  Taken together, the results of this study indicate that RESMENA diet could be considered as a new dietary strategy in order to improve anthropometrical and biochemical parameters in obese subjects presenting MetS manifestations. Furthermore, dietary TAC seems to be, among all the analyzed dietary aspects, the most relevant one in the obesity related markers.

                  Abbreviations

                  AHA: 

                  American Heart Association

                  ALT: 

                  Alanine aminotransferase

                  AST: 

                  Aspartate aminotransferase

                  BMI: 

                  Body mass index

                  DXA: 

                  Dual-energy X-ray Absorptiometry

                  GI: 

                  Glycemic index

                  GL: 

                  Glycemic load

                  HDL-c: 

                  High Density Lipoprotein-cholesterol

                  HEI: 

                  Healthy Eating Index

                  LDL-c: 

                  Low Density Lipoprotein-cholesterol

                  MetS: 

                  Metabolic syndrome

                  PQ: 

                  Protein Quality

                  PUFA: 

                  Poly Unsaturated Fatty Acids

                  TAC: 

                  Total antioxidant capacity

                  WHO: 

                  World Health Organisation.

                  Declarations

                  Acknowledgements

                  This work was supported by the Health Department of the Government of Navarra (48/2009), the Linea Especial about Nutrition, Obesity and Health (University of Navarra LE/97) and CIBERobn and RETICS. Government of Navarra provided a pre-doctoral research grant to Patricia Lopez-Legarrea (Pre-doctoral nº 233/2009). We acknowledge the volunteers for their participation in the study and the physician Blanca E. Martinez de Morentin, the nurse Salome Perez and the technician Veronica Ciaurriz for the excellent technical assistance.

                  Authors’ Affiliations

                  (1)
                  Department of Nutrition, Food Science and Physiology, University of Navarra
                  (2)
                  Biodonostia Health Research Institute
                  (3)
                  Hospital Complex of Navarra
                  (4)
                  CIBERobn. Carlos III Health Research Institute

                  References

                  1. Ejike CE, Ijeh II: Obesity in young-adult nigerians: variations in prevalence determined by anthropometry and bioelectrical impedance analysis, and the development of % body fat prediction equations. Int Arch Med. 2012, 5 (1): 22-10.1186/1755-7682-5-22.View Article
                  2. Hermsdorff HH, Zulet MA, Abete I, Martinez JA: Discriminated benefits of a Mediterranean dietary pattern within a hypocaloric diet program on plasma RBP4 concentrations and other inflammatory markers in obese subjects. Endocrine. 2009, 36 (3): 445-451. 10.1007/s12020-009-9248-1.View Article
                  3. Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet. 2005, 365 (9468): 1415-1428. 10.1016/S0140-6736(05)66378-7.View Article
                  4. Marchetti E, Monaco A, Procaccini L, Mummolo S, Gatto R, Tete S, Baldini A, Tecco S, Marzo G: Periodontal disease: the influence of metabolic syndrome. Nutr Metab (Lond). 2012, 9 (1): 88-10.1186/1743-7075-9-88.View Article
                  5. Aller EE, Abete I, Astrup A, Martinez JA, Van Baak MA: Starches, sugars and obesity. Nutrients. 2011, 3 (3): 341-369.View Article
                  6. Larsen TM, Dalskov SM, Van Baak M, Jebb SA, Papadaki A, Pfeiffer AF, Martinez JA, Handjieva-Darlenska T, Kunesova M, Pihlsgard M, Stender S, Holst C, Saris WH, Astrup A: Diets with high or low protein content and glycemic index for weight-loss maintenance. N Engl J Med. 2010, 363 (22): 2102-2113. 10.1056/NEJMoa1007137.View Article
                  7. Cameron JD, Cyr MJ, Doucet E: Increased meal frequency does not promote greater weight loss in subjects who were prescribed an 8-week equi-energetic energy-restricted diet. Br J Nutr. 2009, 103 (8): 1098-1101.
                  8. Grube B, Chong PW, Lau KZ, Orzechowski HD: A Natural Fiber Complex Reduces Body Weight in the Overweight and Obese: A Double-Blind, Randomized, Placebo-Controlled Study. 2012, Obesity (Silver Spring)
                  9. Peairs AD, Rankin JW, Lee YW: Effects of acute ingestion of different fats on oxidative stress and inflammation in overweight and obese adults. Nutr J. 2011, 10: 122-10.1186/1475-2891-10-122.View Article
                  10. Gogebakan O, Kohl A, Osterhoff MA, Van Baak MA, Jebb SA, Papadaki A, Martinez JA, Handjieva-Darlenska T, Hlavaty P, Weickert MO, Holst C, Saris WH, Astrup A, Pfeiffer AF: Effects of weight loss and long-term weight maintenance with diets varying in protein and glycemic index on cardiovascular risk factors: the diet, obesity, and genes (DiOGenes) study: a randomized, controlled trial. Circulation. 2011, 124 (25): 2829-2838. 10.1161/CIRCULATIONAHA.111.033274.View Article
                  11. Abete I, Goyenechea E, Zulet MA, Martinez JA: Obesity and metabolic syndrome: potential benefit from specific nutritional components. Nutr Metab Cardiovasc Dis. 2010, 21 (Suppl 2): B1-B15.
                  12. Pellegrini N, Serafini M, Salvatore S, Del Rio D, Bianchi M, Brighenti F: Total antioxidant capacity of spices, dried fruits, nuts, pulses, cereals and sweets consumed in Italy assessed by three different in vitro assays. Mol Nutr Food Res. 2006, 50 (11): 1030-1038. 10.1002/mnfr.200600067.View Article
                  13. Ghiselli A, Serafini M, Natella F, Scaccini C: Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radic Biol Med. 2000, 29 (11): 1106-1114. 10.1016/S0891-5849(00)00394-4.View Article
                  14. Puchau B, Zulet MA, De Echavarri AG, Hermsdorff HH, Martinez JA: Dietary total antioxidant capacity: a novel indicator of diet quality in healthy young adults. J Am Coll Nutr. 2009, 28 (6): 648-656.View Article
                  15. Abete I, Parra D, Martinez JA: Legume-, fish-, or high-protein-based hypocaloric diets: effects on weight loss and mitochondrial oxidation in obese men. J Med Food. 2009, 12 (1): 100-108. 10.1089/jmf.2007.0700.View Article
                  16. Ramel A, Martinez JA, Kiely M, Bandarra NM, Thorsdottir I: Effects of weight loss and seafood consumption on inflammation parameters in young, overweight and obese European men and women during 8 weeks of energy restriction. Eur J Clin Nutr. 2010, 64 (9): 987-993. 10.1038/ejcn.2010.99.View Article
                  17. Goto M, Morita A, Goto A, Sasaki S, Aiba N, Shimbo T, Terauchi Y, Miyachi M, Noda M, Watanabe S: Dietary glycemic index and glycemic load in relation to HbA1c in Japanese obese adults: a cross-sectional analysis of the Saku control obesity program. Nutr Metab (Lond). 2012, 9 (1): 79-10.1186/1743-7075-9-79.View Article
                  18. Del Rio D, Agnoli C, Pellegrini N, Krogh V, Brighenti F, Mazzeo T, Masala G, Bendinelli B, Berrino F, Sieri S, Tumino R, Rollo PC, Gallo V, Sacerdote C, Mattiello A, Chiodini P, Panico S: Total antioxidant capacity of the diet is associated with lower risk of ischemic stroke in a large Italian cohort. J Nutr. 2011, 141 (1): 118-123. 10.3945/jn.110.125120.View Article
                  19. Zulet MA, Bondia-Pons I, Abete I, de la Iglesia R, Lopez-Legarrea P, Forga L, Navas-Carretero S, Martinez JA: The reduction of the metabolyc syndrome in Navarra-Spain (RESMENA-S) study: a multidisciplinary strategy based on chrononutrition and nutritional education, together with dietetic and psychological control. Nutr Hosp. 2011, 26 (1): 16-26.
                  20. Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, Erdman JW, Kris-Etherton P, Goldberg IJ, Kotchen TA, Lichtenstein AH, Mitch WE, Mullis R, Robinson K, Wylie-Rosett J, St Jeor S, Suttie J, Tribble DL, Bazzarre TL: AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Stroke. 2000, 31 (11): 2751-2766. 10.1161/01.STR.31.11.2751.View Article
                  21. Alberti KG, Zimmet P, Shaw J: The metabolic syndrome--a new worldwide definition. Lancet. 2005, 366 (9491): 1059-1062. 10.1016/S0140-6736(05)67402-8.View Article
                  22. Food and Nutrition Board, National Research Council: Recomended Dietary Allowances. 1989, Washington, DC: The National Academy Press, 10
                  23. Basiotis PP, Carlson A, Gerrior SA, Juan WY, Lino M: The Healthy Eating Index: 1999–2000 (CNPP-12). 2002, US Department of Agriculture, Center for Nutrition Policy and Promotion
                  24. Loenneke JP, Wilson JM, Manninen AH, Wray ME, Barnes JT, Pujol TJ: Quality protein intake is inversely related with abdominal fat. Nutr Metab (Lond). 2012, 9 (1): 5-10.1186/1743-7075-9-5.View Article
                  25. Carlsen MH, Halvorsen BL, Holte K, Bohn SK, Dragland S, Sampson L, Willey C, Senoo H, Umezono Y, Sanada C, Barikmo I, Berhe N, Willett WC, Phillips KM, Jacobs DR, Blomhoff R: The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J. 2010, 9: 3-10.1186/1475-2891-9-3.View Article
                  26. Foster-Powell K, Holt SH, Brand-Miller JC: International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr. 2002, 76 (1): 5-56.
                  27. Abete I, Astrup A, Martinez JA, Thorsdottir I, Zulet MA: Obesity and the metabolic syndrome: role of different dietary macronutrient distribution patterns and specific nutritional components on weight loss and maintenance. Nutr Rev. 2010, 68 (4): 214-231. 10.1111/j.1753-4887.2010.00280.x.View Article
                  28. Yang HR, Kim HR, Kim MJ, Ko JS, Seo JK: Noninvasive parameters and hepatic fibrosis scores in children with nonalcoholic fatty liver disease. World J Gastroenterol. 2012, 18 (13): 1525-1530. 10.3748/wjg.v18.i13.1525.View Article
                  29. Heden TD, Liu Y, Sims LJ, Whaley-Connell AT, Chockalingam A, Dellsperger KC, Kanaley JA: Meal frequency differentially alters postprandial triacylglycerol and insulin concentrations in obese women. Obesity (Silver Spring). 2012
                  30. Salas-Salvado J, Martinez-Gonzalez MA, Bullo M, Ros E: The role of diet in the prevention of type 2 diabetes. Nutr Metab Cardiovasc Dis. 2011, 21 (Suppl 2): B32-B48.View Article
                  31. Psaltopoulou T, Panagiotakos DB, Pitsavos C, Chrysochoou C, Detopoulou P, Skoumas J, Stefanadis C: Dietary antioxidant capacity is inversely associated with diabetes biomarkers: The ATTICA study. Nutr Metab Cardiovasc Dis. 2009, 21: 561-7.View Article
                  32. Pitsavos C, Panagiotakos DB, Tzima N, Chrysohoou C, Economou M, Zampelas A, Stefanadis C: Adherence to the Mediterranean diet is associated with total antioxidant capacity in healthy adults: the ATTICA study. Am J Clin Nutr. 2005, 82 (3): 694-699.
                  33. Bahadoran Z, Golzarand M, Mirmiran P, Shiva N, Azizi F: Dietary total antioxidant capacity and the occurrence of metabolic syndrome and its components after a 3-year follow-up in adults: Tehran Lipid and Glucose Study. Nutr Metab (Lond). 2012, 9 (1): 70-10.1186/1743-7075-9-70.View Article
                  34. Zulet MA, Puchau B, Hermsdorff HH, Navarro C, Martinez JA: Vitamin A intake is inversely related with adiposity in healthy young adults. J Nutr Sci Vitaminol (Tokyo). 2008, 54 (5): 347-352. 10.3177/jnsv.54.347.View Article
                  35. Puchau B, Zulet MA, De Echavarri AG, Hermsdorff HH, Martinez JA: Dietary total antioxidant capacity is negatively associated with some metabolic syndrome features in healthy young adults. Nutrition. 2010, 26 (5): 534-541. 10.1016/j.nut.2009.06.017.View Article
                  36. Aicher BO, Haser EK, Freeman LA, Carnie AV, Stonik JA, Wang X, Remaley AT, Kato GJ, Cannon RO: Diet-induced weight loss in overweight or obese women and changes in high-density lipoprotein levels and function. Obesity (Silver Spring). 2012, 20 (10): 2057-2062. 10.1038/oby.2012.56.View Article
                  37. Belalcazar LM, Lang W, Haffner SM, Hoogeveen RC, Pi-Sunyer FX, Schwenke DC, Balasubramanyam A, Tracy RP, Kriska AP, Ballantyne CM: Adiponectin and the mediation of HDL-cholesterol change with improved lifestyle: the Look AHEAD Study. J Lipid Res. 2012, 53 (12): 2726-2733. 10.1194/jlr.M030213.View Article
                  38. Smith KM, Barraj LM, Kantor M, Sahyoun NR: Relationship between fish intake, n-3 fatty acids, mercury and risk markers of CHD (National Health and Nutrition Examination Survey 1999–2002). Public Health Nutr. 2009, 12 (8): 1261-1269. 10.1017/S1368980008003844.View Article
                  39. Campbell DD, Meckling KA: Effect of the protein:carbohydrate ratio in hypoenergetic diets on metabolic syndrome risk factors in exercising overweight and obese women. Br J Nutr. 2012, 16: 1-14.
                  40. Okuda N, Ueshima H, Okayama A, Saitoh S, Nakagawa H, Rodriguez BL, Sakata K, Choudhury SR, Curb JD, Stamler J: Relation of long chain n-3 polyunsaturated fatty acid intake to serum high density lipoprotein cholesterol among Japanese men in Japan and Japanese-American men in Hawaii: the INTERLIPID study. Atherosclerosis. 2005, 178 (2): 371-379. 10.1016/j.atherosclerosis.2004.09.007.View Article
                  41. Haidar YM, Cosman BC: Obesity epidemiology. Clin Colon Rectal Surg. 2011, 24 (4): 205-210. 10.1055/s-0031-1295684.View Article
                  42. Giuca MR, Pasini M, Tecco S, Marchetti E, Giannotti L, Marzo G: Skeletal maturation in obese patients. Am J Orthod Dentofacial Orthop. 2012, 142 (6): 774-779. 10.1016/j.ajodo.2012.07.011.View Article
                  43. Park MH, Falconer C, Viner RM, Kinra S: The impact of childhood obesity on morbidity and mortality in adulthood: a systematic review. Obes Rev. 2012, 13 (11): 985-1000. 10.1111/j.1467-789X.2012.01015.x.View Article

                  Copyright

                  © Lopez-Legarrea et al.; licensee BioMed Central Ltd. 2013

                  This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                  Advertisement